Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | FABP4 | P15090 | 1/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5178712 | 0.91 | TTR (0.34) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL3809209 | 0.91 | TTR (0.34) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL4871382 | 0.86 | SNCA (0.30) | SNCA | |
| Sulfurous Acid SCHEMBL8461547 | 0.86 | TTR (0.31) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL571230 | 0.85 | — | — | |
| SCHEMBL1072234 | 0.85 | MEN1 (0.36) | SNCA | |
| Sulfurous Acid SCHEMBL8461551 | 0.84 | TTR (0.30) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL571228 | 0.82 | — | — | |
| SCHEMBL1537228 | 0.79 | SLC16A3 (0.34) | SNCASLC16A3 | |
| SCHEMBL285342 | 0.79 | TRPA1 (0.38) | SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140162083-A1 | STILBENE-BASED REACTIVE COMPOUNDS, POLYMERIC MATRICES FORMED THEREFROM, AND ARTICLES VISUALIZABLE BY FLUORESCENCE | SURMODICS, INC. (US) | 2014-06-12 | — | — | US | claimed |
| US-9629945-B2 | Stilbene-based reactive compounds, polymeric matrices formed therefrom, and articles visualizable by fluorescence | SURMODICS, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| US-20140162083-A1 | STILBENE-BASED REACTIVE COMPOUNDS, POLYMERIC MATRICES FORMED THEREFROM, AND ARTICLES VISUALIZABLE BY FLUORESCENCE | SURMODICS, INC. (US) | 2014-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140162083-A1 | STILBENE-BASED REACTIVE COMPOUNDS, POLYMERIC MATRICES FORMED THEREFROM, AND ARTICLES VISUALIZABLE BY FLUORESCENCE | ITK, NOTUM, ITGAM | TTR 3411/4885FABP4 4635/4885CCNA2 1964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.